8 studies found for:    mesothelioma AND West Virginia
Show Display Options
Rank Status Study
1 Completed PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: PTK787/ZK 222584
2 Completed An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Drug: MORAb-009 (Amatuximab);   Drug: Pemetrexed;   Drug: Cisplatin
3 Terminated A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Condition: Solid Organ Tumors
Intervention:
4 Unknown  Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
5 Unknown  S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Condition: Malignant Mesothelioma
Intervention: Drug: everolimus
6 Active, not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelioid Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatoid Mesothelioma
Interventions: Drug: Cediranib Maleate;   Drug: Cisplatin;   Drug: Pemetrexed Disodium;   Other: Placebo
7 Completed
Has Results
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: gemcitabine hydrochloride;   Drug: carboplatin
8 Recruiting LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)
Condition: Tumors With CDK4/6 Pathway Activation
Intervention: Drug: LEE011

Indicates status has not been verified in more than two years